Events & Presentations

Presentation / Fact Sheet

Upcoming Events

Past Events

Keystone Symposia on Vaccinology: Horizons Across Disease, Demography and Technology

June 4-7, 2025, Washington, DC

Poster Session 1 – Pratima Kumari, PhD, GeoVax Scientist

Poster Number: 1050
Title: “MVA‑vectored multi‑antigen COVID‑19 vaccines induce protective immunity against SARS‑CoV‑2 variants spanning Alpha to Omicron in preclinical animal models.”
When: June 5, 2025 at 12:00 p.m.

Poster Session 2 – Amany Elsharkawy, PhD, Georgia State University Scientist
Poster Number: 2047
Title: “GEO‑CM04S1 vaccine candidate maintains potent cross‑reactivity against original SARS‑CoV‑2 B.1 and Omicron subvariant XBB.1.5.”
When: June 6, 2025 at 7:30 p.m.

For more information on the Keystone Conference, please visit the Keystone Symposia website: https://www.keystonesymposia.org/conferences/conference-listing/meeting/onpage-program/g12025

Q1 2025 GeoVax Labs, Inc. Corporate Update

May 1, 2025 - 4:30 PM ET

Webcast

American Association of Cancer Research

April 25-30, 2025, Chicago, IL

Speaker:	J. Marc Pipas, MD, Executive Medical Director, Oncology
Session Title:	Viral-Vectored, Gene-Directed Prodrug Therapy (Gedeptin) in Needle-Accessible Solid Tumors

World Vaccine Congress Washington 2025

April 22-24, 2025

Speaker:

Don J. Diamond, PhD, Director, Division of Vaccine Research & Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center

Session Title:

Phase 2b Study Results That Evaluated and Compared GeoVax’s Multi-Antigen, Vaccine Candidate (GEO-CM04S1) to an Approved Vaccine Against COVID-19